ALNY

Bullish

Alnylam Pharmaceuticals (ALNY) Valuation After Q1 2026 Profit Breakthrough And Revenue Surge

Alnylam Pharmaceuticals (ALNY) reported a significant shift to net profit in Q1 2026 with combined net product revenues exceeding US$1 billion, markin...

Simply Wall Street 1 week ago 0

Bullish

Needham Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $510

Needham has reiterated its Buy rating on Alnylam Pharmaceuticals (ALNY.US) and maintained its target price of $510. This indicates a continued positiv...

Moomoo 2 weeks ago 0